NEW YORK, NY / ACCESSWIRE / November 9, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Elite Pharmaceuticals Inc (OTC: ELTP),Medical Marijuana Inc (PINKSHEETS: MJNA), Ekso Bionics Holdings Inc (OTC: EKSO) and Pharmacyte Biotech Inc (OTC: PMCB). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
To access our full PDF Research Packages for free, please visit the links below.
============
Full PDF DOWNLOAD Links
(You may have to copy and paste the links into your browser)
ELTP Research Package: http://www.traders-choice.com/pdf?s=ELTP
MJNA Research Package: http://www.traders-choice.com/pdf?s=MJNA
EKSO Research Package: http://www.traders-choice.com/pdf?s=EKSO
PMCB Research Package: http://www.traders-choice.com/pdf?s=PMCB
============
Highlights from today's reports include:
On Friday, November 06, 2015, the NASDAQ Composite ended at 5,147.12, up 0.38%, the Dow Jones Industrial Average edged 0.26% higher to finish the day at 17,910.33, and the S&P 500 closed at 2,099.20, down 0.03%.
- Elite Pharmaceuticals Inc's stock edged higher by 6.14% to close Friday's session at USD 0.42. The company's shares oscillated between USD 0.37 and USD 0.42. The stock recorded a trading volume of 4.63 million shares, which was above its 50-day daily average volume of 1.48 million shares and above its 52-week average volume of 1.30 million shares. The stock is trading above its 50-day and 200-day moving averages of USD 0.25 and USD 0.23, respectively. Over the last three days, Elite Pharmaceuticals Inc's shares have advanced 32.80%. Further, over the last three months, the stock has gained 78.57% and in the past six months, the shares have picked up 90.50%. On a compounded total return basis, the company has returned 46.64% in the past one week, and 92.66% in the past one month. Additionally, the company is trading at a price to earnings ratio of 10.48. This compares to a historical PE ratio of 6.42.
- The stock of Medical Marijuana Inc declined 2.33% to close Friday's session at USD 0.0420. The shares of the company moved in the range of USD 0.0401 and USD 0.0446. A trading volume of 4.45 million shares was recorded, which was lower than its 150-day daily average volume of 5.97 million shares and below its 52-week average volume of 4.95 million shares. Over the last five days, Medical Marijuana Inc's shares have advanced 35.48%. However, over the last three months, the stock has declined 4.00%. The company has returned 36.36% in the past one month on a compounded total return basis. The company has an Enterprise value of USD 76.32 million with Enterprise Value to Revenue ratio of 5.26. Additionally, the company is trading at a price to sales ratio of 5.28 and price to book ratio of 0.56. Further, the stock has an RSI of 50.00.
- Ekso Bionics Holdings Inc's stock decreased by 9.09% to close Friday's session at USD 1.15. The company’s shares fluctuated in the range of USD 1.13 and USD 1.26. A total of 0.59 million shares exchanged hands, which surpassed its 50-day daily average volume of 0.31 million shares and was below its 52-week average volume of 0.60 million shares. The company has an Enterprise value of USD 101.31 million with Enterprise Value to Revenue ratio of 14.74. Over the past one week, Ekso Bionics Holdings Inc's shares have declined by 1.71%. However, over the last three months, the stock has gained 6.48% and in the past six months, the shares have shed 26.28%. The company has returned 0.88% in the past three months, on a compounded total return basis. Further, the company is trading at a price to earnings ratio of 2.46, price to sales ratio of 18.80 and price to book ratio of 9.30.
- Pharmacyte Biotech Inc's stock slipped by 0.69% to close Friday's session at USD 0.1008. The company's shares oscillated between USD 0.0980 and USD 0.1018. The stock recorded a trading volume of 1.05 million shares, which was below its 50-day daily average volume of 1.79 million shares and below its 52-week average volume of 2.36 million shares. The company has a total market capitalization of USD 71.43 million and Enterprise value of USD 71.43 million. Over the last five days, Pharmacyte Biotech Inc's shares have declined by 6.99% and in the past one month, it has gained a momentum of 9.57%. In addition, over the last three months, the stock has lost 3.08%. The stock is trading close to its 50-day moving average and below its 200-day moving average. Additionally, the stock has an RSI of 52.00 and trading at a price to book ratio of 11.28.
--
About Trader's Choice:
Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.
NO WARRANTY
TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.
RESTRICTIONS
TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com
SOURCE: Trader's Choice